Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Seiler

Showing results (171-180 of 220) with videos related to

Pageof 22
Sort By:
Acta Neurochirurgica|January 4, 2005
Treatment outcomes and mortality of 94 patients with acromegalyR Trepp, C Stettler, M Zwahlen, et al.
Developments in Biological Standardization|January 1, 1987
Quality criteria for i.v. immunoglobulins: importance of tests and product propertiesP Gronski, E J Kanzy, H J Ronneberger, et al.
Journal of the National Cancer Institute|April 1, 1979
Characteristics of cytotoxic antibodies against neuraminidase-treated lymphocytes in manR Johannsen, H H Sedlacek, R Schmidtberger, et al.
Zeitschrift Fur Kinderheilkunde|January 1, 1971
[Polysyndactyly, short limbs, and genital malformations--a new syndrome?]F Majewski, R A Pfeiffer, W Lenz, et al.
Gesundheitswesen (Bundesverband Der Arzte Des Offentlichen Gesundheitsdienstes (Germany))|May 7, 2009
[The development of a questionnaire for the assessment of integrated health-care programmes from the patients' perspective (BIGPAT)]R Kilian, C Gonnerman, R Seiler, et al.
Urologic Oncology|June 28, 2024
A 2-center review of histopathology of variants of upper urinary tract urothelial carcinoma and their impact on clinical outcomesN Giudici, A Schoch, V Genitsch, et al.
Behring Institute Mitteilungen|June 1, 1995
Monomeric and dimeric forms of soluble receptors can differ in their neutralization potentialL Lauffer, E J Kanzy, R Köhler, et al.
Behring Institute Mitteilungen|October 1, 1990
Development of an ELISA for the detection and determination of contaminating proteins in recombinant DNA derived human erythropoietinJ U Pauly, B Siebold, R Schulz, et al.
Biotherapy (Dordrecht, Netherlands)|January 1, 1993
Mast cell growth factor (C-kit ligand) in combination with granulocyte-macrophage colony-stimulating factor and interleukin-3: in vivo hemopoietic effects in irradiated mice compared to in vitro effectsM L Patchen, R Fischer, T J MacVittie, et al.
Blut|December 1, 1989
Granulocyte-macrophage colony-stimulating factor binding sites and oxidative metabolism in human granulocytesM Häder, M Klausmann, K H Pflüger, et al.
Pageof 22

Showing results (171-180 of 220) with videos related to

Sort By:
Pageof 22
Acta Neurochirurgica|January 4, 2005
Treatment outcomes and mortality of 94 patients with acromegalyR Trepp, C Stettler, M Zwahlen, et al.
Developments in Biological Standardization|January 1, 1987
Quality criteria for i.v. immunoglobulins: importance of tests and product propertiesP Gronski, E J Kanzy, H J Ronneberger, et al.
Journal of the National Cancer Institute|April 1, 1979
Characteristics of cytotoxic antibodies against neuraminidase-treated lymphocytes in manR Johannsen, H H Sedlacek, R Schmidtberger, et al.
Zeitschrift Fur Kinderheilkunde|January 1, 1971
[Polysyndactyly, short limbs, and genital malformations--a new syndrome?]F Majewski, R A Pfeiffer, W Lenz, et al.
Gesundheitswesen (Bundesverband Der Arzte Des Offentlichen Gesundheitsdienstes (Germany))|May 7, 2009
[The development of a questionnaire for the assessment of integrated health-care programmes from the patients' perspective (BIGPAT)]R Kilian, C Gonnerman, R Seiler, et al.
Urologic Oncology|June 28, 2024
A 2-center review of histopathology of variants of upper urinary tract urothelial carcinoma and their impact on clinical outcomesN Giudici, A Schoch, V Genitsch, et al.
Behring Institute Mitteilungen|June 1, 1995
Monomeric and dimeric forms of soluble receptors can differ in their neutralization potentialL Lauffer, E J Kanzy, R Köhler, et al.
Behring Institute Mitteilungen|October 1, 1990
Development of an ELISA for the detection and determination of contaminating proteins in recombinant DNA derived human erythropoietinJ U Pauly, B Siebold, R Schulz, et al.
Biotherapy (Dordrecht, Netherlands)|January 1, 1993
Mast cell growth factor (C-kit ligand) in combination with granulocyte-macrophage colony-stimulating factor and interleukin-3: in vivo hemopoietic effects in irradiated mice compared to in vitro effectsM L Patchen, R Fischer, T J MacVittie, et al.
Blut|December 1, 1989
Granulocyte-macrophage colony-stimulating factor binding sites and oxidative metabolism in human granulocytesM Häder, M Klausmann, K H Pflüger, et al.
Pageof 22